BIOAGE LABS INC (BIOA) Stock Income Statement
NASDAQ:BIOA - Nasdaq - US09077V1008 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 1.45M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 96.09M | 78.19M | 48.40M | 39.97M | |||
| Research and Development | 70.14M | 59.04M | 33.89M | 30.52M | |||
| Selling, General, and Administrative Expenses | 25.95M | 19.16M | 14.51M | 9.45M | |||
| Operating Income | -94.64M | -78.19M | -48.40M | -39.97M | |||
| Interest Income/Expense | 10.85M | 7.33M | -15.45M | 247.00K | |||
| Non Recurring Items | N/A | -250.00K | N/A | N/A | |||
| Income Before Taxes | -84.04M | -71.11M | -63.85M | -39.72M | |||
| Net Income | -84.04M | -71.11M | -63.85M | -39.72M | |||
| EBITDA | -94.44M | -78.03M | -48.24M | -39.84M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -2.34 | -1.98 | -1.87 | -1.16 | |||
| Statistics | |||||||
| Profit Margin | -5791.66% | N/A | N/A | N/A | |||
| Operating Profit Margin | -6522.40% | N/A | N/A | N/A | |||
All data in USD